These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18442371)

  • 1. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity.
    Christenson B; Pauksen K; Sylvan SP
    Virol J; 2008 Apr; 5():52. PubMed ID: 18442371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons.
    Christenson B; Hedlund J; Lundbergh P; Ortqvist A
    Eur Respir J; 2004 Mar; 23(3):363-8. PubMed ID: 15065822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up.
    Hedlund J; Christenson B; Lundbergh P; Ortqvist A
    Vaccine; 2003 Sep; 21(25-26):3906-11. PubMed ID: 12922125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study.
    Christenson B; Lundbergh P; Hedlund J; Ortqvist A
    Lancet; 2001 Mar; 357(9261):1008-11. PubMed ID: 11293594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan--a representative population-based comparative study.
    Chang YC; Chou YJ; Liu JY; Yeh TF; Huang N
    J Infect; 2012 Sep; 65(3):231-8. PubMed ID: 22561486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive preventive effect of influenza and pneumococcal vaccines in the elderly: results of a large cohort study.
    Mahamat A; Daurès JP; de Wzieres B
    Hum Vaccin Immunother; 2013 Jan; 9(1):128-35. PubMed ID: 23442587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States.
    Simonsen L; Taylor RJ; Young-Xu Y; Haber M; May L; Klugman KP
    mBio; 2011 Jan; 2(1):e00309-10. PubMed ID: 21264063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.
    Domínguez A; Castilla J; Godoy P; Delgado-Rodríguez M; Saez M; Soldevila N; Astray J; Mayoral JM; Martín V; Quintana JM; González-Candelas F; Galán JC; Tamames S; Castro A; Baricot M; Garín O; Pumarola T;
    Hum Vaccin Immunother; 2013 Apr; 9(4):865-73. PubMed ID: 23563516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis.
    Zhang YY; Tang XF; Du CH; Wang BB; Bi ZW; Dong BR
    Hum Vaccin Immunother; 2016 Dec; 12(12):3056-3064. PubMed ID: 27629584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
    Tsai YH; Hsieh MJ; Chang CJ; Wen YW; Hu HC; Chao YN; Huang YC; Yang CT; Huang CC
    Vaccine; 2015 Jun; 33(25):2897-902. PubMed ID: 25936662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection.
    Christenson B; Lundbergh P
    Epidemiol Infect; 2002 Dec; 129(3):515-24. PubMed ID: 12558334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "You need to be an advocate for yourself": Factors associated with decision-making regarding influenza and pneumococcal vaccine use among US older adults from within a large metropolitan health system.
    Kaljee LM; Kilgore P; Prentiss T; Lamerato L; Moreno D; Arshad S; Zervos M
    Hum Vaccin Immunother; 2017 Jan; 13(1):206-212. PubMed ID: 27625007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
    Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
    N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60.
    Betsch C; Rossmann C; Pletz MW; Vollmar HC; Freytag A; Wichmann O; Hanke R; Hanke W; Heinemeier D; Schmid P; Eitze S; Weber W; Reinhardt A; Küpke NK; Forstner C; Fleischmann-Struzek C; Mikolajetz A; Römhild J; Neufeind J; Rieck T; Suchecka K; Reinhart K
    BMC Public Health; 2018 Jul; 18(1):885. PubMed ID: 30012141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of influenza vaccine on response to vaccination with pneumococcal vaccine in HIV patients.
    Ranieri R; Veronelli A; Santambrogio C; Pontiroli AE
    AIDS Res Hum Retroviruses; 2005 May; 21(5):407-9. PubMed ID: 15929703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study.
    Kondo K; Suzuki K; Washio M; Ohfuji S; Fukushima W; Maeda A; Hirota Y;
    Vaccine; 2017 Aug; 35(36):4806-4810. PubMed ID: 28818473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching.
    Song JY; Noh JY; Lee JS; Wie SH; Kim YK; Lee J; Jeong HW; Kim SW; Lee SH; Park KH; Choi WS; Cheong HJ; Kim WJ
    PLoS One; 2018; 13(12):e0207918. PubMed ID: 30521553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis.
    Yin M; Huang L; Zhang Y; Yu N; Xu X; Liang Y; Ni J
    Expert Rev Vaccines; 2018 Jul; 17(7):653-663. PubMed ID: 29961353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease.
    Nichol KL
    Vaccine; 1999 Jul; 17 Suppl 1():S91-3. PubMed ID: 10471189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.
    Nair H; Watts AT; Williams LJ; Omer SB; Simpson CR; Willocks LJ; Cameron JC; Campbell H
    BMC Infect Dis; 2016 Aug; 16():390. PubMed ID: 27506837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.